Literature DB >> 9642213

High-affinity binding of epidermal growth factor (EGF) to EGF receptor is disrupted by overexpression of mutant dynamin (K44A).

T Ringerike1, E Stang, L E Johannessen, D Sandnes, F O Levy, I H Madshus.   

Abstract

Activation of the epidermal growth factor receptor (EGFR) kinase was analyzed in cells conditionally defective for clathrin-dependent endocytosis by overexpression of mutant dynamin (K44A). EGF-induced autophosphorylation of the EGFR on ice was strongly reduced in cells overexpressing mutant dynamin, and consistently, binding analyses showed that high-affinity EGFRs were lost. In the absence of mutant dynamin the cells displayed both high- and low-affinity EGFR. At 4 degreesC EGF-EGFR localized mainly outside coated pits regardless of expression of mutant dynamin. However, also low-affinity EGFR efficiently moved to coated pits upon incubating cells at 37 degreesC. Thus, expression of mutant dynamin disrupts high-affinity binding of EGF, but not ligand-induced recruitment of EGFR to clathrin-coated pits.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9642213     DOI: 10.1074/jbc.273.27.16639

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  On the nature of low- and high-affinity EGF receptors on living cells.

Authors:  Ferruh Ozcan; Peter Klein; Mark A Lemmon; Irit Lax; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-29       Impact factor: 11.205

2.  Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane.

Authors:  Leiliane P Sousa; Irit Lax; Hongying Shen; Shawn M Ferguson; Pietro De Camilli; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

3.  The first step of adenovirus type 2 disassembly occurs at the cell surface, independently of endocytosis and escape to the cytosol.

Authors:  M Y Nakano; K Boucke; M Suomalainen; R P Stidwill; U F Greber
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

4.  Endosomal localization and receptor dynamics determine tyrosine phosphorylation of hepatocyte growth factor-regulated tyrosine kinase substrate.

Authors:  S Urbé; I G Mills; H Stenmark; N Kitamura; M J Clague
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

5.  Thermodynamic mixing of molecular states of the epidermal growth factor receptor modulates macroscopic ligand binding affinity.

Authors:  M R Holbrook; L L Slakey; D J Gross
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

6.  Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms.

Authors:  L E Johannessen; K E Haugen; A C østvold; E Stang; I H Madshus
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

7.  Preformed oligomeric epidermal growth factor receptors undergo an ectodomain structure change during signaling.

Authors:  Marisa Martin-Fernandez; David T Clarke; Mark J Tobin; Samantha V Jones; Gareth R Jones
Journal:  Biophys J       Date:  2002-05       Impact factor: 4.033

8.  Cellular localization of the activated EGFR determines its effect on cell growth in MDA-MB-468 cells.

Authors:  Dustin C Hyatt; Brian P Ceresa
Journal:  Exp Cell Res       Date:  2008-09-11       Impact factor: 3.905

9.  EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo.

Authors:  Itziar Pinilla-Macua; Alexandre Grassart; Umamaheswar Duvvuri; Simon C Watkins; Alexander Sorkin
Journal:  Elife       Date:  2017-12-21       Impact factor: 8.140

10.  Single-molecule imaging and fluorescence lifetime imaging microscopy show different structures for high- and low-affinity epidermal growth factor receptors in A431 cells.

Authors:  Stephen E D Webb; Selene K Roberts; Sarah R Needham; Christopher J Tynan; Daniel J Rolfe; Martyn D Winn; David T Clarke; Roger Barraclough; Marisa L Martin-Fernandez
Journal:  Biophys J       Date:  2007-09-21       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.